| BeaconEquity Initiates Independent Research Coverage for Keryx ... - Trading Markets (press release) |
|
|
Trading Markets (press release)Zerenex is in phase II clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end stage renal disease ... read more |